Article in GoingPublic Special Issue: Case Study “Mit einem gefäßschützenden Antikörper gegen septischen Shock”

2. October 2019

Read the full article about Adrenomed on page 104 of the GoingPublic Special Issue “Biotechnologie 2019” (Article in German).

Illustration: Adrenomed AG

CONTACT

Contact Info

  • +49 (0) 3302 20 77 8 0
  • +49 (0) 3302 20 77 8 15
  • info@adrenomed.com
  • ADRENOMED AG

Neuendorfstraße 15A 
Hennigsdorf b. Berlin 
D-16761, Germany.

Twitter
Linkedin

© 2021 Adrenomed AG | Imprint/Impressum | Legal Notice/Datenschutzerklärung